Weill Cornell Medicine, New York-Presbyterian Hospital, Illumina Collaborate on Scalable Clinical Whole-Genome Sequencing Initiative
December 04, 2020
December 04, 2020
NEW YORK, Dec. 4 -- New York-Presbyterian Hospital issued the following news release:
Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease and potentially reveal previously unidentified therapies for treatment. The initiative, which also includes . . .
Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients, in order to identify genetic alterations driving disease and potentially reveal previously unidentified therapies for treatment. The initiative, which also includes . . .